|
Speciality
|
Scientific Advisor
Intensive Care and Emergency Medicine
Translational Medicine
Biochemistry and Genetic Engineering |
|
About
|
Dr Alex Melhuish is a medical doctor and Scientific Advisor at NeuroTest24, with an academic background in genetic engineering, biochemistry, and translational medicine.
He earned his BSc (Hons) in Genetic Engineering from Queen Mary, University of London, in 2003, followed by an MSc by Research in Biochemistry from the University of Kent in 2005, with a focus on molecular and translational medicine. He subsequently obtained his MD from I.P. Pavlov First St Petersburg State Medical University in 2012.
His professional background includes two years in translational medicine (2012–2014) and a four-year residency in intensive care and emergency medicine (2014–2018).
Dr Melhuish is affiliated with several professional medical and scientific organisations, including the Royal College of Physicians, the European Respiratory Society, and societies dedicated to translational medicine. |
|
Professional Experience
|
● Scientific Advisor – NeuroTest24
● Translational Medicine – Two years of professional experience (2012–2014).
● Intensive Care and Emergency Medicine – Four-year residency training (2014–2018). |
|
Certifications
|
● Doctor of Medicine (MD) – I.P. Pavlov First St Petersburg State Medical University, 2012.
● MSc by Research in Biochemistry – University of Kent, UK, 2005.
● BSc (Hons) in Genetic Engineering – Queen Mary, University of London, UK, 2003.
● Residency Training in Intensive Care and Emergency Medicine, 2014–2018. |
|
Memberships
|
● International Affiliate – Royal College of Physicians
● Member – European Respiratory Society
● Member – Pancyprian Medical Association
● Member – Society for Translational Medicine
● Member – European Society for Translational Medicine |
|
|